CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study

Autor: Minson, Adrian, Hamad, Nada, Cheah, Chan Y., Tam, Constantine, Blombery, Piers, Westerman, David, Ritchie, David, Morgan, Huw, Holzwart, Nicholas, Lade, Stephen, Anderson, Mary Ann, Khot, Amit, Seymour, John F., Robertson, Molly, Caldwell, Imogen, Ryland, Georgina, Saghebi, Javad, Sabahi, Zahra, Xie, Jing, Koldej, Rachel, Dickinson, Michael
Zdroj: In Blood 22 February 2024 143(8):673-684
Databáze: ScienceDirect